Read more

November 09, 2022
11 min listen
Save

Healio Minute Podcast, Gastroenterology Edition: Top Headlines - Week of November 7, 2022

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

In this edition, achalasia is associated with higher esophageal cancer risk; FDA rejects bulevirtide for hepatitis D and liver disease; real-world data on colonoscopy prep and more.

Read the full coverage here:

Achalasia associated with five-fold higher risk for esophageal cancer

FDA rejects Gilead’s bulevirtide for hepatitis D, compensated liver disease

Polyethylene glycol, ascorbic acid cleanse highly effective for colonoscopy prep

Distal cap-assisted endoscopic mucosal resection safe, effective for fibrotic polyps

FDA backs EndoStim’s neurostimulation implant for GERD control

References:

Arieira C, et al. Abstract S589: One-Liter Polyethylene Glycol + Ascorbic Acid Bowel Preparation Delivers High Levels of Adequate and High-Quality Bowel Cleansing for Colonoscopy. Presented at: ACG Annual Scientific Meeting; Oct. 21-26, 2022; Charlotte, N.C. (hybrid meeting).

Douglas SR, et al. Abstract S130: Distal Cap-Assisted Endoscopic Mucosal Resection Is a Safe and Effective Technique for Resection of Non-Lifting or Adherent Colorectal Polyps: An International, Multicenter, Retrospective Study. Presented at: ACG Annual Scientific Meeting; Oct. 21-26, 2022; Charlotte, N.C. (hybrid meeting).

Low EE, et al. Abstract S388: Risk of esophageal cancer in achalasia: A matched cohort study utilizing the veterans affairs achalasia cohort (VA-AC). Presented at: ACG Annual Scientific Meeting; Oct. 21-26, 2022; Charlotte, N.C. (hybrid meeting).

Press Release

Press Release

Sources/Disclosures

Collapse

Disclosures: Please see each study for relevant financial disclosures.